US Stock MarketDetailed Quotes

HCW Biologics (HCWB)

Watchlist
  • 1.248
  • -0.072-5.45%
Trading Jun 12 13:15 ET
8.94MMarket Cap-0.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HCW Biologics (HCWB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
129,080.67%6.54M
-97.89%54.23K
-93.16%27.01K
-96.34%15.61K
-98.94%6.55K
-99.55%5.07K
-9.68%2.57M
-70.18%394.8K
-50.02%426.42K
-0.63%618.85K
Operating revenue
129,080.67%6.54M
-97.89%54.23K
-93.16%27.01K
-96.34%15.61K
-98.94%6.55K
-99.55%5.07K
-9.68%2.57M
-70.18%394.8K
-50.02%426.42K
-0.63%618.85K
Cost of revenue
173.22%11.07K
-97.30%43.39K
-93.16%21.61K
-96.34%12.49K
-98.80%5.24K
-99.21%4.05K
-29.54%1.61M
-70.52%315.84K
-49.71%341.14K
-12.73%438.44K
Gross profit
644,710.46%6.53M
-98.87%10.85K
-93.16%5.4K
-96.34%3.12K
-99.27%1.31K
-99.84%1.01K
71.21%959.4K
-68.75%78.96K
-51.20%85.29K
49.84%180.41K
Operating expense
93.76%3.28M
-60.59%11.27M
9.40%2.95M
-13.00%3.28M
-76.01%3.36M
-79.11%1.69M
8.79%28.59M
-75.51%2.7M
-28.23%3.77M
202.67%14.02M
Selling and administrative expenses
1,051.98%1.77M
-74.54%5.59M
-2.29%1.56M
-27.71%1.82M
-82.58%2.08M
-97.40%153.81K
67.72%21.95M
-55.06%1.6M
-28.64%2.51M
304.16%11.92M
-General and administrative expense
1,051.98%1.77M
-74.54%5.59M
-2.29%1.56M
-27.71%1.82M
-82.58%2.08M
-97.40%153.81K
67.72%21.95M
-55.06%1.6M
-28.64%2.51M
304.16%11.92M
Research and development costs
-14.93%1.26M
-14.81%5.44M
27.01%1.33M
18.31%1.4M
-39.54%1.23M
-30.36%1.48M
-16.77%6.39M
-50.87%1.05M
-28.82%1.19M
25.52%2.03M
Depreciation amortization depletion
-12.02%53.88K
-6.84%237.01K
13.24%58.16K
-15.74%58.45K
-11.19%59.16K
-8.71%61.24K
-4.63%254.41K
-34.42%51.36K
9.97%69.37K
2.81%66.62K
-Depreciation and amortization
-12.02%53.88K
-6.84%237.01K
13.24%58.16K
-15.74%58.45K
-11.19%59.16K
-8.71%61.24K
-4.63%254.41K
-34.42%51.36K
9.97%69.37K
2.81%66.62K
Provision for doubtful accounts
----
----
----
----
----
----
-75.24%1.3M
----
----
----
Other taxes
--198.15K
----
----
----
----
--0
----
----
----
----
Operating profit
292.00%3.25M
59.26%-11.26M
-12.49%-2.95M
11.07%-3.28M
75.70%-3.36M
77.41%-1.69M
-7.43%-27.63M
75.67%-2.62M
27.44%-3.68M
-206.75%-13.84M
Net non-operating interest income expense
76.61%-123.69K
-5.81%-1.25M
71.24%-226.54K
37.76%-142.57K
-107.28%-330.96K
-528.88K
-317.46%-1.18M
-55,453.48%-787.68K
-139.82%-229.06K
-67.17%-159.67K
Non-operating interest expense
-76.61%123.69K
5.81%1.25M
-71.24%226.54K
-37.76%142.57K
107.28%330.96K
--528.88K
317.46%1.18M
55,453.48%787.68K
139.82%229.06K
67.17%159.67K
Other net income (expense)
2,632.36%676.23K
474.92%4.55M
11,154.25%3.89M
-10,136.60%-1.14M
237.41%1.77M
-3.33%24.75K
-220.59%-1.21M
-59.89%34.59K
-95.18%11.31K
-525.88%-1.28M
Gain on sale of security
--667.34K
---537.4K
---1.14M
---1.15M
--1.75M
----
----
----
----
----
Special income (charges)
----
---1.5M
----
---182.15K
----
----
--0
92.41%-148.95K
--0
-628.62%-10.39M
-Less:Impairment of capital assets
----
--1.5M
----
----
----
----
--0
----
----
----
-Less:Other special charges
----
----
----
----
----
----
142.11%15.91M
-92.41%148.95K
-54.25%949.46K
628.62%10.39M
-Gain on sale of property,plant,equipment
----
----
----
---182.15K
----
----
----
----
--0
----
Other non- operating income (expenses)
-64.09%8.89K
642.88%6.59M
18,779.07%6.53M
17.51%13.29K
101.27%16.37K
-3.33%24.75K
-220.59%-1.21M
-59.89%34.59K
-95.18%11.31K
-525.88%-1.28M
Income before tax
273.09%3.8M
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
Income tax
330.19K
0
Net income
258.06%3.47M
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
Net income continuous Operations
258.06%3.47M
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
Minority interest income
Net income attributable to the parent company
258.06%3.47M
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
Preferred stock dividends
Other preferred stock dividends
1.49M
14.34M
4.19M
0
10.15M
0
0
0
0
0
Net income attributable to common stockholders
190.31%1.98M
25.73%-22.3M
-2.75%-3.47M
-16.71%-4.55M
20.93%-12.08M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
Basic earnings per share
118.78%0.37
65.67%-10.63
68.13%-1.02
51.09%-2.02
57.98%-6.79
75.38%-1.97
-10.57%-30.96
73.33%-3.2
26.25%-4.13
-236.67%-16.16
Diluted earnings per share
118.78%0.37
65.67%-10.63
68.13%-1.02
51.09%-2.02
57.98%-6.79
75.38%-1.97
-10.57%-30.96
73.33%-3.2
26.25%-4.13
-236.67%-16.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 129,080.67%6.54M-97.89%54.23K-93.16%27.01K-96.34%15.61K-98.94%6.55K-99.55%5.07K-9.68%2.57M-70.18%394.8K-50.02%426.42K-0.63%618.85K
Operating revenue 129,080.67%6.54M-97.89%54.23K-93.16%27.01K-96.34%15.61K-98.94%6.55K-99.55%5.07K-9.68%2.57M-70.18%394.8K-50.02%426.42K-0.63%618.85K
Cost of revenue 173.22%11.07K-97.30%43.39K-93.16%21.61K-96.34%12.49K-98.80%5.24K-99.21%4.05K-29.54%1.61M-70.52%315.84K-49.71%341.14K-12.73%438.44K
Gross profit 644,710.46%6.53M-98.87%10.85K-93.16%5.4K-96.34%3.12K-99.27%1.31K-99.84%1.01K71.21%959.4K-68.75%78.96K-51.20%85.29K49.84%180.41K
Operating expense 93.76%3.28M-60.59%11.27M9.40%2.95M-13.00%3.28M-76.01%3.36M-79.11%1.69M8.79%28.59M-75.51%2.7M-28.23%3.77M202.67%14.02M
Selling and administrative expenses 1,051.98%1.77M-74.54%5.59M-2.29%1.56M-27.71%1.82M-82.58%2.08M-97.40%153.81K67.72%21.95M-55.06%1.6M-28.64%2.51M304.16%11.92M
-General and administrative expense 1,051.98%1.77M-74.54%5.59M-2.29%1.56M-27.71%1.82M-82.58%2.08M-97.40%153.81K67.72%21.95M-55.06%1.6M-28.64%2.51M304.16%11.92M
Research and development costs -14.93%1.26M-14.81%5.44M27.01%1.33M18.31%1.4M-39.54%1.23M-30.36%1.48M-16.77%6.39M-50.87%1.05M-28.82%1.19M25.52%2.03M
Depreciation amortization depletion -12.02%53.88K-6.84%237.01K13.24%58.16K-15.74%58.45K-11.19%59.16K-8.71%61.24K-4.63%254.41K-34.42%51.36K9.97%69.37K2.81%66.62K
-Depreciation and amortization -12.02%53.88K-6.84%237.01K13.24%58.16K-15.74%58.45K-11.19%59.16K-8.71%61.24K-4.63%254.41K-34.42%51.36K9.97%69.37K2.81%66.62K
Provision for doubtful accounts -------------------------75.24%1.3M------------
Other taxes --198.15K------------------0----------------
Operating profit 292.00%3.25M59.26%-11.26M-12.49%-2.95M11.07%-3.28M75.70%-3.36M77.41%-1.69M-7.43%-27.63M75.67%-2.62M27.44%-3.68M-206.75%-13.84M
Net non-operating interest income expense 76.61%-123.69K-5.81%-1.25M71.24%-226.54K37.76%-142.57K-107.28%-330.96K-528.88K-317.46%-1.18M-55,453.48%-787.68K-139.82%-229.06K-67.17%-159.67K
Non-operating interest expense -76.61%123.69K5.81%1.25M-71.24%226.54K-37.76%142.57K107.28%330.96K--528.88K317.46%1.18M55,453.48%787.68K139.82%229.06K67.17%159.67K
Other net income (expense) 2,632.36%676.23K474.92%4.55M11,154.25%3.89M-10,136.60%-1.14M237.41%1.77M-3.33%24.75K-220.59%-1.21M-59.89%34.59K-95.18%11.31K-525.88%-1.28M
Gain on sale of security --667.34K---537.4K---1.14M---1.15M--1.75M--------------------
Special income (charges) -------1.5M-------182.15K----------092.41%-148.95K--0-628.62%-10.39M
-Less:Impairment of capital assets ------1.5M------------------0------------
-Less:Other special charges ------------------------142.11%15.91M-92.41%148.95K-54.25%949.46K628.62%10.39M
-Gain on sale of property,plant,equipment ---------------182.15K------------------0----
Other non- operating income (expenses) -64.09%8.89K642.88%6.59M18,779.07%6.53M17.51%13.29K101.27%16.37K-3.33%24.75K-220.59%-1.21M-59.89%34.59K-95.18%11.31K-525.88%-1.28M
Income before tax 273.09%3.8M73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M
Income tax 330.19K0
Net income 258.06%3.47M73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M
Net income continuous Operations 258.06%3.47M73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M
Minority interest income
Net income attributable to the parent company 258.06%3.47M73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M
Preferred stock dividends
Other preferred stock dividends 1.49M14.34M4.19M010.15M00000
Net income attributable to common stockholders 190.31%1.98M25.73%-22.3M-2.75%-3.47M-16.71%-4.55M20.93%-12.08M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M
Basic earnings per share 118.78%0.3765.67%-10.6368.13%-1.0251.09%-2.0257.98%-6.7975.38%-1.97-10.57%-30.9673.33%-3.226.25%-4.13-236.67%-16.16
Diluted earnings per share 118.78%0.3765.67%-10.6368.13%-1.0251.09%-2.0257.98%-6.7975.38%-1.97-10.57%-30.9673.33%-3.226.25%-4.13-236.67%-16.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.38%
Sample Name
Sample Code
 +0.48%
Sample Name
Sample Code
 -1.94%
4
ProShares Ultra Energy
DIG
-2.12%
5
VanEck Oil Services ETF
OIH
-2.69%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.61%
Sample Name
Sample Code
 +10.30%
Sample Name
Sample Code
 +8.48%
4
Qifu Technology
QFIN
+5.85%
5
NetEase
NTES
+5.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -